In Case 1, it is noteworthy that other hallmark characteristics of GBM, such as EGFR amplification, TERT promoter mutations, or gains of chromosome 7 with loss of chromosome 10, as well as other driver alterations in high-grade CNS neoplasms, were absent. The gene discussed is EGFR; the disease is central nervous system neoplasm.